Moartea unei fetițe după un experiment de editare genetică zguduie lumea medicală. Anchetă la un spital de prestigiu din China

The death of a girl following an experimental gene-editing treatment has sparked a major investigation in China, raising ethical concerns about medical advancements. The child suffered from a rare genetic disorder and her parents funded a groundbreaking therapy at a prestigious university. After treatment, she developed severe complications and died, with the hospital's ethics committee linking her death to the experimental procedure. The case has drawn attention due to a related study published without mentioning the patient's death. Experts highlight ongoing issues of transparency and accountability in rapidly advancing genetic therapies, prompting potential regulatory changes in China.